MYSCREW PATH ASSIST
LIVE

Serial Number

79445572

Owner

Siemens Healthineers AG

Filing Date

Jan 23, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MYSCREW PATH ASSIST Trademark

Serial Number: 79445572

MYSCREW PATH ASSIST is a trademark filed by Siemens Healthineers AG on January 23, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Siemens Healthineers AG (7 trademarks)

Siemensstraße 3

Entity Type: 99

Trademark Details

Filing Date

January 23, 2026

Registration Date

Not Registered

Goods & Services

Software as a service (SaaS) services featuring software for use in connection with controlling and operating an apparatus for medical imaging; software as a service (SaaS) services featuring software for monitoring, recording, analysing and storing medical image data and for configuring, processing, organising and updating imaging protocols.

Recorded and downloadable software, in particular recorded and downloadable software for use in connection with controlling and operating a medical imaging apparatus; recorded and downloadable software for monitoring, recording, analysing and storing medical image data and for configuring, processing, organising and updating imaging protocols being a component of medical imaging apparatus; recorded and downloadable computer software integrated into a medical imaging device for monitoring, recording, analysing and storing medical image data and for configuring, processing, organising and updating imaging protocols.

Filing History

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 26, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jun 25, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 7, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 6, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 13, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 12, 2026 REPR